The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
British bulls record on gdr stinks
Anyway , it's blue for once lets hope we get a few days of blue
Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=GDR.L
Not so sure about the April fools it.
British Bulls on it
April fools was yesterday
Expecting rise in price and more news this week..!!
"Cant beat solid statements , the markets dont lie."
Neither does the share price chart!
"Once it’s profitable it could move up on to the main market."
Your imagination is on a different level.! GDR on the cuss of bankruptcy and here you are talking about a full listing!!!!!!!!
Once it’s profitable it could move up on to the main market.
If it's bought out it will be taken private. I'm 100% convinced of that. If they get to the point where sales cover their costs then why share all the profit with other share holders and take on all the faff that comes with being a listed company. I really hope that doesn't happen but AIM is so bad at the moment what with the Financial Authorities turning a blind eye to even the most obvious rip offs on AIM taking place on such a regular basis these days.
The right time to get in will be when under new ownership imo!
For me it is the other way round, get funding in place to give the company time to get everything else in place , Cheek is a can do type but that will only go so far, FDA could be as little as 6 months , a partner to help fund it , special commissioning , why the delay with the stroke test if it is nothing to do with the test, more overseas sales, will all take time . Funding is the main priority for me .
'm amazed this held up after what was a poor report.
Everything talked about is still due to happen but further down the track. The longer it goes on the easier it is for RF or other activist investors - I am 100% some ii has been shorting GDR all the way down from 30p. And don't bother to look at the tab above because in the vast majority of AIM cases this website doesn't report any shorting at all even though it is known to be happening.
For me. the first big question is when does this turn properly and when do I get back in. The second big question - and will impact what I do regarding Q1 - is when will some properly good news land.
Seems clear to me they are making progress on sales but not nearly enough yet to shift the dial on being self sufficient.
The only news that will help turn this around in the near future is FULL recommendation for AIHL so all of the NHS Neo natal units have to use the test. That means a guaranteed income of a few £m per year. This is the game changer. After this point, when sales will cover the company's annual costs and it no longer has to rely on outside funding things will look very different. Perhaps this is the point someone makes a move to buy out GDR?
Can GDR get to that magical moment before they are so desperate for funding that it either goes bust or has to pretty much give most of the company away in what would be for lths a catastrophic dilution? Who knows. As things stand it's tight but imho I think GDR is just the wrong side of that red line. It has suffered terribly from NHS delays and poor decisions from senior management. Luck and good timing are now in the lap of the gods for this outfit.
I might be wrong but I have a feeling the NICE news due in July for the CYP2C19 test will also require significant data gathering and so that is pretty much 18 months behind AIHL. I also now think the FDA partnership seems to be more based on this test rather than AIHL so even if this lands I'm not convinced this would provide the turning point investors need to be assured of success over the next few years.
Can GDR get to that magical moment
Thruppence a share pathetic
Cant beat solid statements , the markets dont lie.
Look on the bright side, that annual revenue will cover a fortnight of the company’s cash burn !
Very “solid”…
Frankly that article was laughable.
"Summing up Genedrive's interim results, the company delivered solid revenue growth, narrowed its operating loss significantly, and achieved material operational progress for its lead assets MT-RNR1 and CYP2C19. "
Agreed stocksaint.
How a company trading for 11 years can say sales went from 20,000k to 200,000k and calling that SOLID is beyond me. A penny pusher on Brighton pier arcade probably generates more....
Good to see an improvement in Sales, although the numbers could and should have been better, but I suppose any steps forward is positive news. Don't understand why he would need to raise funds with the drawdown facility still in place, any further dilution will see this company sink further down with next to nothing coming in. This company had a good track record when it came to raising funds without heavy dilution. I hope Mr Cheek bears that in mind when he goes about the next fundraise.
Ah, you need to read the small print.
"Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence."
:- )
Maybe Cheek wrote the draft copy
I love this line from the article. Comedy gold:
"Summing up Genedrive's interim results, the company delivered solid revenue growth, narrowed its operating loss significantly, and achieved material operational progress for its lead assets MT-RNR1 and CYP2C19. "
Cheek abler to defer the inevitable a little bit longer while rinsing shareholders.
The man has balls of steel!
Stock i agree that as far as we know , but if we are in talks regarding financing then those talks could be a little further down the road ??.
Hope so.
Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=GDR.L
Are British Bulls correct!
That’s a very misleading article, especially the header..
It says that FDA approval is progressing, but as I understand it they have held only preliminary discussions (well over a year ago!) and have yet to even start the FDA approval process proper. Indeed that is why they are seeking a US partner. Something promised by the CEO at the start of the year but which we are yet to see.